tyrosine has been researched along with Dysphagia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, K; Deguchi, K; Deguchi, S; Hishikawa, N; Kono, S; Matsuzono, K; Motomura, M; Nakano, Y; Ohta, K; Ota, Y; Sato, K; Tanabe, K; Yamashita, T | 1 |
| Fujita, Y; Furuta, N; Ikeda, M; Ikeda, Y; Ishizawa, K; Makioka, K; Motomura, M; Nagamine, S; Okamoto, K; Shibata, M; Tsukagoshi, S; Yoshimura, S | 1 |
| Clayton, BE; Smith, I; Wolff, OH | 1 |
3 other study(ies) available for tyrosine and Dysphagia
| Article | Year |
|---|---|
Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
Topics: Adult; Ambulatory Care; Autoantibodies; Deglutition Disorders; Humans; Immunoglobulins, Intravenous; Male; Muscle Weakness; Myasthenia Gravis; Plasma Exchange; Plasmapheresis; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Tyrosine | 2018 |
Anti-MuSK Antibody-positive Myasthenia Gravis Mimicking Amyotrophic Lateral Sclerosis.
Topics: Aged; Amyotrophic Lateral Sclerosis; Autoantibodies; Biomarkers; Deglutition Disorders; Disease Progression; Drug Administration Schedule; Female; Glucocorticoids; Humans; Middle Aged; Myasthenia Gravis; Prednisolone; Receptor Protein-Tyrosine Kinases; Receptors, Cholinergic; Treatment Outcome; Tyrosine | 2015 |
New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
Topics: Biopterins; Child; Child, Preschool; Deglutition Disorders; Dihydropteridine Reductase; Female; Humans; Infant; Intellectual Disability; Male; Neuromuscular Diseases; Phenylalanine; Phenylketonurias; Seizures; Tyrosine | 1975 |